| HOME >> MEDICINE >> TECHNOLOGY |
1.2 List of Figures 8
2 Contract Manufacturing Organizations to 2018 - Introduction 9
3 Contract Manufacturing Organizations to 2018 - Industry Overview 10
3.1 Current Status of Pharmaceutical Industry 10
3.2 Cost Optimization Steps for the Pharmaceutical Companies 10
3.2.1 Reduction in Physical Assets 11
3.2.2 Downsizing Manufacturing 11
3.2.3 Reduction in R&D Spending 11
3.3 What CMOs are and Reasons for Outsourcing to Them 13
3.3.1 Different Types of CMOs and the Range of Services Provided by Them 14
3.3.2 How Does Outsourcing to CMOs Take Place? 15
3.3.3 Key Outsourcing Models 17
3.3.4 Key Benefits of Outsourcing 19
4 Contract Manufacturing Organizations to 2018 - Market Characterization 21
4.1 Market Forecasts 21
5 Contract Manufacturing Organizations to 2018 - Geographical Landscape 23
5.1 Introduction 23
5.2 Established Markets 24
5.2.1 The US CMO Market 24
5.2.2 The Eastern European CMO Market 25
5.3 Emerging Markets 27
5.3.1 The Indian CMO Market 27
5.3.2 The Chinese CMO Market 29
6 Contract Manufacturing Organizations to 2018 - Market Drivers and Restraints 31
6.1 Global CMO Market Drivers 32
6.1.1 Availability of Low-cost Skilled Manpower 32
6.1.2 Increasing Government Sanctions are Favoring CMOs 34
6.1.3 Increased Consumption of Generics 34
6.1.4 Better Intellectual Property Rights Protection 39
6.1.5 Increasing Uptake of Biologics and Entry of Biosimilars into Market 40
6.2 Global CMO Market Restraints 41
6.2.1 Capacity Utilization Issues Affecting the Profitability of CMOs 41
6.2.2 Reduced Number of New Drug Approvals 41
6.2.3 Complex Cost Structures in Outsourcing 44
7 Contract Manufacturing Organizations to 2018 - Regulatory Framework 45
7.1 Overview 45
7.2 FDA Guideline
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |